These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3094264)

  • 1. [Kinetics of the antibody level in schistosomiasis under chemotherapy].
    Schlisio W; Ziegler K
    Z Gesamte Inn Med; 1986 Aug; 41(15):422-7. PubMed ID: 3094264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunofluorescence serologic findings in schistosomiasis. Methodologic aspects].
    Schlisio W; Möller FW; Ziegler K
    Z Gesamte Inn Med; 1989 Mar; 44(5):149-52. PubMed ID: 2496532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren.
    Creasey AM; Taylor P; Thomas JE
    Cent Afr J Med; 1986 Jul; 32(7):165-7. PubMed ID: 3107836
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
    Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
    Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and tolerance of praziquantel in schistosomiasis].
    Groning E; Bakathir H; Salem A; Albert L; Fernández R
    Rev Cubana Med Trop; 1985; 37(2):215-9. PubMed ID: 3938555
    [No Abstract]   [Full Text] [Related]  

  • 6. Praziquantel compared to niridazole in schistosomiasis intercalatum therapy.
    Feldmeier H; Zwingenberger K; Steiner A; Dietrich M
    Tropenmed Parasitol; 1981 Mar; 32(1):39-42. PubMed ID: 7233551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of some aspects of cell mediated immune response in bilharzial children on a field level.
    el-Hawey AM; Massoud AM; el-Rakieby A; Royzeik MS; Nassar MO
    J Egypt Soc Parasitol; 1991 Aug; 21(2):411-6. PubMed ID: 1908498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative trials of regimes for the treatment of urinary schistosomiasis in The Gambia.
    Wilkins HA; Moore PJ
    J Trop Med Hyg; 1987 Apr; 90(2):83-92. PubMed ID: 3104624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of praziquantel efficiency in the treatment of schistosomiasis.
    Khalil HM; el-Hawey AM; Abdel Baki MH; el-Hadi HM; Sharara MO
    J Egypt Soc Parasitol; 1986 Dec; 16(2):403-12. PubMed ID: 3097166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schistosomiasis prevalence after administration of praziquantel to school children in Melela village, Morogoro region, Tanzania.
    Kitange HM; Swai AB; McLarty DG; Alberti KG
    East Afr Med J; 1993 Dec; 70(12):782-6. PubMed ID: 8026352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Praziquantel in treatment of S. mansoni and S. haematobium infections.
    Ahmed TH; Ali AA; Bassiouni GA; Omer SH; Shalaby MA
    J Egypt Soc Parasitol; 1988 Jun; 18(1):313-24. PubMed ID: 3131447
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of eosinophil cationic protein as a possible diagnostic marker for female genital schistosomiasis in women living in a Schistosoma haematobium endemic area.
    Midzi N; Ndhlovu PD; Nyanga L; Kjetland EF; Reimert CM; Vennervald BJ; Gomo E; Mudenge G; Friis H; Gundersen SG; Mduluza T
    Parasite Immunol; 2003; 25(11-12):581-8. PubMed ID: 15053779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of praziquantel in Egyptian schistosomiasis.
    Ismail MM; Bruce JI; Attia MM; el-Ridi AM; Shabayek HA; Salama MM
    J Egypt Soc Parasitol; 1986 Jun; 16(1):259-67. PubMed ID: 3088142
    [No Abstract]   [Full Text] [Related]  

  • 15. Performance of IgG avidity in an area endemic for schistosomiasis in Egypt.
    Abou-Basha LM; Shehab AY; Abdel-Fattah M; Bassili A
    East Mediterr Health J; 2002 Jan; 8(1):172-80. PubMed ID: 15330573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in chronic Schistosomiasis haematobium and mansoni. Reversibility of alterations after anti-parasitic treatment with praziquantel.
    Feldmeier H; Gastl GA; Poggensee U; Daffalla AA; Nogueira-Queiroz JA; Capron A; Peter HH
    Scand J Immunol; 1988 Aug; 28(2):147-55. PubMed ID: 3137653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schistosomiasis at Marselisborg hospital 1981-1990].
    Tarp BD; Andersen PL
    Ugeskr Laeger; 1996 Feb; 158(7):911-4. PubMed ID: 8638328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
    Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
    Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A ten-year follow-up observation on serum antibody level in schistosomiasis patients treated with praziquantel].
    Xu S; Xia Z; Zhan F; Xu L
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1995; 13(2):142-4. PubMed ID: 7554166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of early treatment with praziquantel on serum connective tissue metabolite markers in children and adolescents with intestinal schistosomiasis mansoni.
    Hassanein HI; Zoheiry MM; Voss B; el Attar GM; Hassan SI; Demerdash ZA; el Baz HM; Yousif OA
    Arzneimittelforschung; 1997 Jan; 47(1):84-7. PubMed ID: 9037450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.